MAR 13 2003
510(k) Summary of Safety and Effectiveness
Gyrus PSR System
Koa sit
pene
Submitted by: Gyrus Medical Inc.
6655 Wedgwood Road, Suite 105
Maple Grove, MN 55311-3602
Contact Person: Mark Jensen
Vice President RA/QA
Telephone: 763-416-3005
Facsimile: 763-416-3070
Date Summary Prepared: September 11, 2002
Name of the Device:
Proprietary Name: Gyrus Plasma Skin Resurfacing (PSR) System
Common/Usual Name: Electrosurgical Generator and Accessories
Classification Name: Electrosurgical Device (per 21 CFR 878.4400)
Predicate Devices: Arthrocare Visage (K992180)
Thermage Thermacool TC System (K013639)
Lumenis (Coherent) UltraPulse CO2 Laser (K974789)
Description: The Gyrus Medical PSR System is intended for treatment of the following
dermatological conditions:
e Superficial skin lesions
e Actinic Keratosis
e Viral papillomata
¢ Sceborrhoeic Keratosis
Accessories included with the generator are a cable assembly/instrument, power cable
and a footswitch.

Statement of Intended Use: The Gyrus PSR System is intended for
treatment of dermatological conditions.

This device is intended for use by qualified
medical personnel trained in the use of
electrosurgery.

Comparison to Predicate Devices: The Gyrus PSR System has been carefully
compared to legally marketed devices with
respect to intended use and safety and
effectiveness. In addition, performance
validation testing has been done to validate
the performance of the device. The
comparison and validation results presented
in this 510(k) notification to the FDA show that

ve - wo ce the—device is substantially equivalent to. =
predicate devices and is safe and effective in
its intended use.

my
e Wa DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
MAR 1 3 2003
Mr. Mark Jensen /
Vice President RA/QA
Gyrus Medical, Inc.
6655 Wedgwood Road, Suite 105
Maple Grove, Minnesota 55311
Re: K023111
Trade/Device Name: Gyrus Plasma Skin Resurfacing (PSR) System
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI
Dated: December 31, 2002
Received: December 31, 2002
Dear Mr. Jensen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class IT] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determinatien does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Mark Jensen
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the
promotion and advertising of your device, please contact the Office of Compliance at (301) 5944639. Also, please note the regulation entitled, "Misbranding by reference to premarket
notification” (21CFR Part 807.97) you may obtain. Other general information on your
responsibilities under the Act may be obtained from the Division of Small Manufacturers,
International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597
or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Piston C Paoverd

Ua Peto.
ly Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health ‘

Enclosure ,

Gyrus Medical Inc. $10(k) Premarket Notification
December 16, 2002 Gyrus PSR System
Indications for Use
510(k) Number (if known): Not Yet Assigned kK OAZsil /
Device Name: Gyrus PSR System
ELECTROSURGICAL GENERATOR
Indications For Use:
The Gyrus Medical PSR System is intended for treatment of the following dermatological
conditions:
e¢ Superficial skin lesions
¢ Actinic Keratosis
e Viral papillomata
¢ Sceborrhoeic Keratosis
—--_-- —-_The-systemis-intendedferuse—by—qualified—-medical-personneltrained—in-the-use-of --————electrosurgical equipment.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) ~
Prescription Use _X OR Over-The-Counter Use __
(Per 21 CFR 801.109)
(Optional Format 1-2-96)
j
wow C Trev _ |
(Division Sign-Off) _
Division of General, Restorative
and Neurological Devices
K G23) |
510(k) Number -___-______—
